SEC Form 4 · accession 0001140361-15-040050
BIOMARIN PHARMACEUTICAL INC · BMRN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jeffrey Robert Ajer
Officer — SVP, Chief Commercial Of
Period of report
Oct 30, 2015
Accepted (ET)
Nov 6, 2015 · 5:44 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001048477
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Oct 30, 2015 | A | 26 | $57.2635 | A | 35,631 | D | |
| Common StockF2,F3,F4 | Nov 2, 2015 | S | 26 | $117.56 | D | 35,605 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The reporting person is reporting the purchase of shares of the issuer's Employee Stock Purchase Plan ("ESPP"), for the ESPP purchase period of May 1, 2015 to October 31, 2015.
- F2Transaction made pursuant to a Rule 10b5-1 trading plan executed on December May 11, 2015.
- F3Due to administrative oversight the reported transaction, which should have been filed 11/4/2015 is being reported late.
- F4All shares sold at same price.